Together, this suggests that invasive breast carcinoma overexpresses leptin compared to normal breast tissue and that leptin levels may also be a potential prognostic factor for ER+/PR+ invasive breast carcinomas. The gene discussed is ESR1; the disease is invasive breast carcinoma.